Identification of predictive biomarkers of overall survival (OS) in patients (pts) with advanced renal cell carcinoma (RCC) treated with interferon alpha (I) with or without bevacizumab (B): Results from CALGB 90206 (Alliance)

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Nixon, AB; Halabi, S; Shterev, I; Starr, M; Brady, JC; Dutcher, JP; Hopkins, JO; Hurwitz, H; Small, EJ; Rini, BI; Febbo, PG; George, DJ

Published Date

  • May 20, 2013

Published In

Volume / Issue

  • 31 / 15

Published By

Pages

  • 1

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Conference Name

  • 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)

Conference Location

  • Chicago, IL

Conference Start Date

  • May 31, 2013

Conference End Date

  • June 4, 2013